Positive results were presented on Tripeps ChronVac-C® vaccine in combination with InoviosTM MedpulserTM technology at the 2nd Hepatitis C Conference in Dublin on June 23

In an oral presentation at the 2nd Hepatitis C conference in Dublin did Professor Matti Sällberg from Karolinska Institutet present that the combination of Tripeps ChronVac-C® vaccine and InoviosTM MedpulserTM DNA Delivery System for in vivo electroporation works well in mouse models. Mice vaccinated using the combined technology show protection against growth of tumor cells expressing hepatitis C virus proteins. “We are very pleased with how the collaboration with InovioTM has developed and have high hopes for this project” says Tripeps CEO Jan Nilsson. For more information, please contact: Rolf L. Nordström, Chairman, Tripep AB Tel: +44 20 7495 1480, mobile phone: +44 7776 137 400 E-mail: rolf.l.nordstrom@btinternet.com Jan Nilsson, CEO, Tripep AB Tel: +46 8 449 84 80, mobile phone: +46 70 466 31 63 E-mail: jan.nilsson@tripep.se Anders Vahlne, Head of Research, Tripep AB Tel: +46 8 5858 1313, mobile phone: +46 709 28 05 28 E-mail: anders.vahlne@ki.se